McDonald Partners’s iShares Biotechnology ETF IBB Stock Holding History

McDonald Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,481	Closed	-$409K	–	243
2022 Q2	$409K	Buy	3,481 +63	+2%	+$7.48K	0.1%	198
2022 Q1	$445K	Buy	+3,418	New	+$445K	0.1%	215
2021 Q4	–	Sell	-3,048	Closed	-$493K	–	624
2021 Q3	$493K	Buy	3,048 +605	+25%	+$102K	0.12%	192
2021 Q2	$400K	Buy	2,443 +150	+7%	+$23.1K	0.09%	213
2021 Q1	$345K	Buy	2,293 +190	+9%	+$30.2K	0.09%	222
2020 Q4	$319K	Buy	+2,103	New	+$301K	0.09%	217

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

McDonald Partners's IBB Position: Q3 2022 in Review

McDonald Partners sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 3,481 shares — an estimated $409K sold.

McDonald Partners first reported a position in IBB in Q4 2020 and held it in 6 quarters. The position peaked at $493K in Q3 2021. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

McDonald Partners reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
McDonald Partners sold 3,481 iShares Biotechnology ETF shares in Q3 2022, an estimated $409K.
McDonald Partners first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 6 quarters.
McDonald Partners's iShares Biotechnology ETF position peaked at $493K in Q3 2021.
829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on McDonald Partners's 13F filing for Q3 2022, filed 21 Oct 2022.